These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12816697)

  • 1. [The clinical significance of SSA antigen and its different positive expressions].
    Li YJ; Liu L; Zhang FC
    Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):165-8. PubMed ID: 12816697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
    Zhang FC; Liu L; Xu D
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
    Touloupi E; Routsias JG; Tzioufas AG
    Clin Exp Immunol; 2005 Oct; 142(1):172-9. PubMed ID: 16178873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
    López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
    J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
    Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
    Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnostic value of anti-SSA antibody in primary Sjögren's syndrome].
    Li MT; Zhao Y; Zheng WJ; Su JM; Wu QJ; Jiang Y; Xu D; Zhang W; Zhang FC; Dong Y
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):410-3. PubMed ID: 20646416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value.
    Langguth DM; Morris S; Clifford L; Wilson RJ; Neil J; Hogan PG; Wong RC
    J Clin Pathol; 2007 Jun; 60(6):670-3. PubMed ID: 17557869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of SSA antigen epitopes in minor salivary glands from patients with primary Sjögren's syndrome].
    Li HB; Zhang FC; Zhang X; Gan XD; Shi YP; Bai YN; Tang FL
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(17):1187-91. PubMed ID: 20646566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein.
    Ottosson L; Salomonsson S; Hennig J; Sonesson SE; Dörner T; Raats J; Kuchroo VK; Sunnerhagen M; Wahren-Herlenius M
    Scand J Immunol; 2005 Feb; 61(2):109-18. PubMed ID: 15683447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity.
    Cozzani E; Drosera M; Siccardi M; Babbini G; Parodi A
    J Rheumatol; 2008 Jul; 35(7):1320-2. PubMed ID: 18528967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
    Katano K; Kawano M; Koni I; Sugai S; Muro Y
    J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
    Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
    Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear antibodies: clinical correlations and biologic significance.
    Sontheimer RD; McCauliffe DP; Zappi E; Targoff I
    Adv Dermatol; 1992; 7():3-52; discussion 53. PubMed ID: 1371222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TS1-RNA: characterization of novel antibodies against sequence-specific RNA by random RNA selection in patients with Sjögren's syndrome.
    Hirokawa K; Takasaki Y; Takeuchi K; Kaneda K; Ikeda K; Hashimoto H
    J Rheumatol; 2002 May; 29(5):931-7. PubMed ID: 12022352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.